 The research has been hailed a ` tour de force , raising hopes the body 's immune system could be trained to attack melanoma , pancreatic , breast and lung cancer .
The team at Stanford University School of Medicine believe the laboratory-engineered antibodies could eradicate not only primary tumours , but also distant metastases that have spread through the body .